Tur vs TUR plus adriamycin in patients with superficial bladder cancer--a five-year follow-up.
Burk
K
K
Farmitalia Carlo Erba GmbH/D-Freiburg.
Schultze-Seemann
W
W
Rodeck
G
G
D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D001743:Urinary Bladder / Q000601:surgery*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000601:surgery*
D004317:Doxorubicin